The European & Developing Countries Clinical Trials Partnership (EDCTP) funds clinical research to accelerate the development of new or improved drugs, vaccines, microbicides and diagnostics against HIV/AIDS, tuberculosis and malaria as well as other poverty-related infectious diseases in sub-Saharan Africa, with a focus on phase II and III clinical trials.
Video on EDCTP
A short animated video explaining the EDCTP programme’s Why, What and How in 210 seconds.
Find it on the EDCTP YouTube channel Edctpmedia.
EDCTP 2003-2018
Overview of selected EDCTP-funded clinical studies for medical interventions against poverty-related infectious diseases, 2003-2018. To date, EDCTP has achieved significant success in bringing together researchers and institutions in Europe and Africa, conducting clinical research and developing research capacity in sub-Saharan Africa.
Europe & Africa
EDCTP is one of the EU’s flagship programmes, contributing towards the European Research Area in multiple ways.
EDCTP delivers added value for countries and organisations in sub-Saharan Africa.
Latest news
World TB Day: EDCTP investments in TB research rise to EUR 127 million
World Tuberculosis Day on 24 March 2019 is themed ‘It’s time’. As the World Health Organisation (WHO) explains, the theme underlines “the urgency to act” on the commitments made by global leaders in September 2018. At the United Nations TB…
ASAAP clinical study of malaria treatment for children has started
A large clinical study evaluating a triple plus combination of antimalarials for children has started in Ghana. The study is coordinated by Dr. Oumou Maiga-Ascofare of the Kumasi Centre for Collaborative Research at the Kwame Nkrumah University of Science and…